← Back to Search

Behavioural Intervention

Patient Activation Program for Low Anterior Resection Syndrome

N/A
Recruiting
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test whether a LARS Patient-Centered Program is more effective than usual care in improving PROMs after restorative proctectomy.

Eligible Conditions
  • Low Anterior Resection Syndrome
  • Colorectal Cancer
  • Patient Activation
  • Surgery
  • Low Anterior Resection
  • Anterior Resection Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Global quality of life (QoL)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Activation ArmExperimental Treatment1 Intervention
Group II: Standard Care ArmActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Centre Hospitalier du QuebecUNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER
437 Previous Clinical Trials
158,893 Total Patients Enrolled
Jewish General HospitalLead Sponsor
137 Previous Clinical Trials
271,916 Total Patients Enrolled

Media Library

Patient Activation Booklet and nursing support (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03828318 — N/A
Anterior Resection Syndrome Research Study Groups: Standard Care Arm, Patient Activation Arm
Anterior Resection Syndrome Clinical Trial 2023: Patient Activation Booklet and nursing support Highlights & Side Effects. Trial Name: NCT03828318 — N/A
Patient Activation Booklet and nursing support (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03828318 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the geographical locations that offer access to this research?

"This clinical trial has 6 open locations in Canada, including McGill University Health Centre (Montréal), CHU de Quebec (Québec) and Jewish General Hospital (Montreal). An additional 3 sites are located elsewhere."

Answered by AI

What is the number of individuals included in this clinical trial?

"Affirmative, according to clinicaltrials.gov the trial is actively recruiting patients and has been since September 1st 2019. The study requires 128 participants from 6 medical sites with its most recent update being on August 17th 2022."

Answered by AI

Does this trial accommodate individuals aged seventy-five and above?

"According to the study's entry requirements, prospective participants must be 18 years or older and not exceed 99."

Answered by AI

Am I eligible to join this research endeavor?

"Candidates wishing to participate in this medical trial must demonstrate symptoms of the relevant syndrome, as well as fall within a specified age range (18 - 99). This study is aiming to recruit around 128 people."

Answered by AI

Does this research require any further participants?

"Confirmed. Clinicaltrials.gov notes that this medical trial, which was initially posted on September 1st 2019, is actively accepting patients for study enrolment. The protocol calls for 128 participants to be recruited from 6 separate sites of care."

Answered by AI
~23 spots leftby Mar 2025